TTS Pharma

Biomedical + Healthcare

A speciality pharma company with a focus on delivering Companion Diagnostic (CDx) Healthcare into PR China.

The Company’s lead product suite targets the Smoking Cessation market with proven products for all three treatment pathways whilst pipeline development is focused on Pain and Dementia. The Company has its own GMP production facility in China and welcomes new development projects.

Our Point of Care diagnostic, the NicoTest®, allows unprecedented rapid testing at the Point of Sale. The NicoTest® means that smokers provide us with a saliva sample at their chosen point of care/ Pharmacist and complete an online lifestyle questionnaire about their smoking habits. We carry out ‘realtime’ tests on their DNA to identify the nature of their most likely response to treatment and, if Nicotine, what the optimum dosage and product format should be. We offer a Personalised Treatment Programme (PTP) to maximise their chances of giving up successfully using off the shelf products available through local reimbursement programmes.


We also have one of UK’s first generic NRT gum formulations which will be available from Q2 2014 across Independent Pharmacies in UK and will follow this with other recognised and established treatments such as our Nicotine patch which we believe will be smaller, less skin irritant and yet provide higher levels of Nicotine Replacement than most marketed brands.

Our ethos of ‘Right drug, right dose, right patient’, has been clinically validated in the NHS to improve quit rates by up to 54{694b0f593b0805c211280362d031b32951511cced51f3077f642d9584f827de9}.

We are also in negotiations to export our diagnostics and manufacturing technologies further afield.

Contact Details

Liverpool Science Park
Innovation Centre 1,
131 Mount Pleasant
L3 5TF

Visit Website